Gastrointestinal System - Irritable Bowel Syndrome

Practice Guidance Toolkit


Gastrointestinal System - Irritable Bowel Syndrome: FODMAP Summary of Recommendations and Evidence

Disclaimer

[B] The following conclusions are supported by fair evidence:
Data from several short-term (<6 weeks) controlled clinical trials suggests that a low FODMAP diet can reduce gastrointestinal symptoms (i.e. abdominal pain, bloating, excessive flatus), compared to no dietary intervention in up to 75% of individuals with IBS. Beneficial effects of the low FODMAP diet on objective fecal measurements are modest or not evident (e.g. fecal frequency, consistency and weight), and some evidence suggests
Continue Reading!

Login or signup to access PEN® premium content.

start free trial

Are you an existing member? Login here.

Last Updated: 2018-07-24